Weighted Average Number of Shares Outstanding, Basic of REGENEREX PHARMA, INC. from Q3 2012 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
REGENEREX PHARMA, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q3 2012 to Q3 2025.
  • REGENEREX PHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 281,463,410, a 1.1% increase year-over-year.
  • REGENEREX PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 278,727,759, a 0.39% increase from 2023.
  • REGENEREX PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 277,653,029, a 0.2% increase from 2022.
  • REGENEREX PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 277,112,660, a 51% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

REGENEREX PHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 281,463,410 +3,181,848 +1.1% 01 Jul 2025 30 Sep 2025 10-Q 17 Nov 2025 2025 Q2
Q2 2025 281,123,410 +2,897,170 +1% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2024 Q1
Q1 2025 278,727,759 +1,074,730 +0.39% 01 Jan 2025 31 Mar 2025 10-K 30 Jun 2025 2024 FY
Q4 2024 278,436,236 +516,739 +0.19% 01 Oct 2024 31 Dec 2024 10-Q 07 Feb 2025 2024 Q3
Q3 2024 278,281,562 +765,204 +0.28% 01 Jul 2024 30 Sep 2024 10-Q 17 Nov 2025 2025 Q2
Q2 2024 278,226,240 +1,069,954 +0.39% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2024 Q1
Q1 2024 277,653,029 +540,369 +0.2% 01 Jan 2024 31 Mar 2024 10-K 30 Jun 2025 2024 FY
Q4 2023 277,919,497 +50,806,837 +22% 01 Oct 2023 31 Dec 2023 10-Q 07 Feb 2025 2024 Q3
Q3 2023 277,516,358 +403,698 +0.15% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q2
Q2 2023 277,156,286 +150,043,626 +118% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q1
Q1 2023 277,112,660 +93,698,630 +51% 01 Jan 2023 31 Mar 2023 10-K 24 Jun 2024 2023 FY
Q4 2022 227,112,660 +23,369,565 +11% 01 Oct 2022 31 Dec 2022 10-Q 05 Feb 2024 2023 Q3
Q3 2022 277,112,660 +150,000,000 +118% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q2
Q2 2022 127,112,660 0 0% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q1
Q1 2022 183,414,030 01 Jan 2022 31 Mar 2022 10-K 09 Jun 2023 2023 FY
Q4 2021 203,743,095 01 Oct 2021 31 Dec 2021 10-Q 24 Jan 2023 2022 Q3
Q3 2021 127,112,660 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q2
Q2 2021 127,112,660 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q1
Q2 2017 156,062,660 0 0% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2017 2017 Q1
Q1 2017 156,062,660 0 0% 01 Jan 2017 31 Mar 2017 10-Q 07 Nov 2017 2017 Q2
Q2 2016 156,062,660 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q1
Q1 2016 156,062,660 01 Jan 2016 31 Mar 2016 10-Q 07 Nov 2017 2017 Q2
Q2 2014 151,152,341 +1,293,902 +0.86% 28 Feb 2014 31 May 2014 10-Q 16 Jul 2014 2014 Q2
Q1 2014 151,132,444 +2,054,444 +1.4% 01 Dec 2013 28 Feb 2014 10-Q 11 Apr 2014 2014 Q1
Q3 2013 151,107,016 +10,056,214 +7.1% 01 Jun 2013 31 Aug 2013 10-Q 02 Oct 2013 2013 Q3
Q2 2013 149,858,439 28 Feb 2013 31 May 2013 10-Q 16 Jul 2014 2014 Q2
Q1 2013 149,078,000 01 Dec 2012 28 Feb 2013 10-Q 11 Apr 2014 2014 Q1
Q3 2012 141,050,802 01 Jun 2012 31 Aug 2012 10-Q 02 Oct 2013 2013 Q3

REGENEREX PHARMA, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 278,727,759 +1,074,730 +0.39% 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025 2024 FY
2023 277,653,029 +540,369 +0.2% 01 Apr 2023 31 Mar 2024 10-K 30 Jun 2025 2024 FY
2022 277,112,660 +93,698,630 +51% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024 2023 FY
2021 183,414,030 01 Apr 2021 31 Mar 2022 10-K 09 Jun 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.